(Q46107321)
Statements
The need for multiple doses of 400 mg ketoconazole as a precipitant inhibitor of a CYP3A substrate in an in vivo drug-drug interaction study (English)
368-9; author reply 370
1 reference
1 reference
1 reference
1 reference
1 reference